Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update
David Wojciechowski, Flavio VincentiKidney Transplant Service, University of California, San Francisco, CA, USAAbstract: In June 2011, the US Food and Drug Administration approved belatacept for the prophylaxis of organ rejection in adult kidney transplant recipients. This review discusses the use o...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/abfcf8c1a4c946dba0610b7dfa88f69c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!